Evidence map›Paper›PMID 30413869›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2019

Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.

Lida Feyz, Dominic A Theuns, Rohit Bhagwandien, Mihai Strachinaru, Isabella Kardys, Nicolas M Van Mieghem, Joost Daemen

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04055285 (Effect of Renal Denervation on Atrial Fibrillation), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04055285 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Effect of Renal Denervation on Atrial Fibrillation

TypeinterventionalSponsorHippocration General HospitalRan2020 to 2022Enrolled30ConditionsArterial Hypertension, Atrial FibrillationArmsSympathetic Renal Denervation, Implantable Loop Recorder
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Systematic review of renal denervation for the management of cardiac arrhythmias.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Pooled it
  2. Association between atrial fibrillation and Helicobacter pylori.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study.Clinical research in cardiology : official journal of the German Cardiac Society · 2023
    Article
  8. Renal Sympathetic Denervation for Hypertension.Kidney international reports · 2022
    Review
  9. Management of atrial fibrillation: two decades of progress - a scientific statement from the European Cardiac Arrhythmia Society.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2022
    Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Neural Mechanisms and Therapeutic Opportunities for Atrial Fibrillation.Methodist DeBakey cardiovascular journal · 2021
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Renal sympathetic nerve activity regulates cardiovascular energy expenditure in rats fed high salt.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lida FeyzDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Dominic A TheunsDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Rohit BhagwandienDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Mihai StrachinaruDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Isabella KardysDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Nicolas M Van MieghemDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
Joost DaemenDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Room Rg6, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. j.daemen@erasmusmc.nl.
Erasmus MC · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe purpose of this pilot study was to assess whether renal sympathetic denervation (RDN) decreases atrial fibrillation (AF) burden in hypertensive patients with symptomatic AF at 6- and 12-month follow-up, as measured using an implantable cardiac monitor (ICM). METHODS AND

resultsA total of 20 patients with symptomatic paroxysmal or persistent AF (EHRA ≥ II) and primary hypertension with a mean office systolic blood pressure (BP) of > 140 mmHg were enrolled. After enrolment, an ICM was implanted 3 months pre-RDN to monitor AF burden. Quality of life (QOL) was assessed using the Atrial Fibrillation Effect on QualiTy-of-life (AFEQT) questionnaire. Mean age was 64 ± 7 years and 55% were females. AF burden in min/day decreased from a median (IQR) of 1.39 (0-11) pre-RDN to 0.67 (0-31.6) at 6 months (p = 0.64) and to 0.94 (0-6.0) at 12 months (pre-RDN vs. 12 months; p = 0.03). QOL improved significantly at both 6 months (+ 11 ± 15 points, p = 0.006) and 12 months (+ 10 ± 19, p = 0.04) as compared to pre-RDN. Office BP decreased significantly at 12-month follow-up (- 20 ± 19/- 7 ± 10 mmHg), p < 0.01) as compared to pre-RDN. Ambulatory BP decreased - 7 ± 16/- 3 ± 9 mmHg (p > 0.05) at 12-month follow-up as compared to pre-RDN.

conclusionThis pilot study suggests that RDN might be able to decrease AF burden in min/day as measured using an ICM, with a positive effect on QOL. Large-scale randomized trials are needed to prove the definite value of RDN in hypertensive patients with atrial fibrillation.

Indexed as

Catheter AblationAgedAtrial FibrillationBlood PressureFemaleHeart RateHumansHypertensionKidneyMaleMiddle AgedPilot ProjectsQuality of LifeRenal ArterySympathectomyTime FactorsAFAtrial fibrillationImplantable cardiac monitorQuality of lifeRDNRenal sympathetic denervation

Identifiers

PMID30413869
PMCPMC6529371
OpenAlexW2900060433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.